Conflict of interest
Torben Harsløf received lecture fees from Amgen, Astra Zeneca, and Eli Lilly and lecture fees and travel grants from UCB. Bente Lomholt Langdahl has received research funding to her institution from Amgen and Novo Nordisk. Bente Lomholt Langdahl serves on advisory boards and speaker’s bureau for Amgen, UCB, Gilead, and Gedeon-Richter. Rawan Hikmet has no conflicts of interest to declare.